Strength
400 mg/1
Manufacturer
Gilead Sciences, Inc.NDC
61958150101
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
3/23/2016
Active Ingredients
SOFOSBUVIRApproval Type
New Drug (NDA)
FDA Application
NDA204671On Market Since
12/6/2013
Pharmacological Classes
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
RNA Replicase Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.